Bristol Myers Squibb employs roughly 24,735 people across its global operations. Recent staffing activity shows 1,699 new hires alongside 2,029 departures, keeping overall headcount stable at the mid-twenty-thousand level. The mix of scientific, commercial, and corporate roles supports the company’s research, manufacturing, and market-facing initiatives within the pharmaceutical industry.
Engineering is the largest function at Bristol Myers Squibb with 6,152 employees, accounting for about one-quarter of the total workforce and reflecting the scale of manufacturing and technical operations required in drug development. Business Management follows with 3,921 employees, while Sales & Support and Operations employ 2,969 and 2,805 people respectively, underscoring the importance of commercial reach and supply-chain execution. Additional sizeable teams include Healthcare professionals (2,377) who provide clinical and scientific expertise, and a 1,708-person Marketing & Product organization that drives brand and portfolio strategy. Finance & Administration (1,207), Quality (799), and Human Resources (697) round out the core corporate functions, with a further 2,100 employees classified in other specialized areas.
The workforce is concentrated in multiple hubs, led by New York, NY with 2,596 employees. Princeton, NJ hosts 1,187 staff, reflecting the company’s longstanding presence in the state. Additional U.S. centers include Seattle, WA (837), Boston, MA (758), Philadelphia, PA (758), Tampa, FL (357), and San Diego, CA (343). Internationally, Hyderabad, India employs 443 colleagues and Ireland accounts for 318, while 2,428 employees work in other global sites. This geographic distribution indicates a blend of research, commercial, and manufacturing locations that support regional and worldwide operations.